Howard Eichenbaum, Ph.D.

Dr. Eichenbaum is at the Center for Memory and Brain, Boston University.

Dr. Eichenbaum has been a consultant to Saegis Pharmaceuticals within the past three years.

This activity is made possible by an unrestricted educational grant from Forest Laboratories.

Release Date: 01/06/2004
Termination Date: 01/06/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Describe the physiological requirements for long-term potentiation and long-term depression
• Describe the cellular mechanisms by which glutamate mediates long-lasting synaptic plasticity
• Describe how AMPA and NMDA receptors contribute to memory.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity